Uptake or Heartbreak with Biosimilars? Progress and Perspectives

Webinar Recorded on Feb. 24, 2021 

To download a copy of the webinar slides, please complete this request form.

While biosimilars have made great strides since the first US launch in 2015, have they achieved the level of impact first anticipated? Some argue there is still room for growth, including questions around the role reimbursement and formulary placement play in their level of adoption. This webinar will look at how payer decision-making is affecting overall adoption of biosimilars, cost reduction and ultimately impact on patients.

Join this session to hear our group of experts discuss:

• Current biosimilars reimbursement trends
• Payer perception and treatment of biosimilars in formulary decision making
• Key considerations for manufacturers to support effective reimbursement and formulary placement
• What’s on the horizon in the biosimilars space

Moderator: 

• Jocelyn Ulrich, MPH
  Deputy Vice President, Policy, Research and Membership
  PhRMA

Speakers: 

• April M. Kunze
  Sr. Director, Clinical Formulary Development & Trend Management Strategy
  Prime Therapeutics
• Laurie Fazio
  Head of Market Access
  FormularyDecisions
• Amanda O’Hora
  Senior Director, Reimbursement Policy Insights
  Xcenda